Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|July 1, 2001
Supplements and Featured Publications
- Improving the Treatment of Epilepsy in the Era of Managed Care
- Volume 7
- Issue 7 Suppl
Pharmacokinetics of the New Antiepileptic Drugs
Author(s)Barry E. Gidal, PharmD
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
Introductionabout 25 years ago
Evaluation of the Patient with Epilepsyabout 25 years ago
The Role of New Antiepileptic Drugsabout 25 years ago
Treatment of Epilepsy in Three Specialized Populationsabout 25 years ago
Roundtable Discussionabout 25 years ago
Continuing Medical Education Quizabout 25 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
4
Early Secukinumab Sustains Psoriasis Clearance a Year After Stopping
5